HEALTHCARE

Allergan Q4 Strong

Allergan PLC reported strong fourth-quarter revenue of $4.3 billion, up 12% from a year earlier, and full-year revenue of nearly $16 billion, a 9.4% increase.

Tease photo

Allergan Appoints CFO

Allergan PLC named Matthew Walsh chief financial officer, effective “later this month.”

Tease photo

Edwards to Build on Strong Q4

Edwards Lifesciences Corp. finished the year strong, reporting $889 million in fourth-quarter sales, up 16% from a year earlier.

Tease photo

Aerie Offering Comes in at $74M

Aerie Pharmaceuticals Inc. sold 1.3 million shares of common stock for $74 million.

Tease photo

Bonti Lands $15.5 Million Series C

Newport Beach-based Bonti closed $15.5 million in series C financing.

Tease photo

Salaam Heisman Fetches Nearly $400K

Rashaan Salaam’s Heisman Trophy attracted nearly $400,000 in an auction run by Laguna Niguel-based SCP Auctions.

Tease photo

Providence St. Joseph’s Wexler Fills Out Team

Providence St. Joseph Health Southern California Chief Executive Erik Wexler named most of an executive team to oversee 14 hospitals in Orange County, and Los Angeles and San Bernardino counties.

Tease photo

Botox Competitor Files for IPO

Evolus Inc. plans an IPO of up to $75 million, according to documents filed with the SEC Tuesday.

Tease photo

Peregrine Changes Name

Tustin-based Peregrine Pharmaceutical Inc. changed its name to Avid Bioservices Inc., now that it’s a dedicated contract development and manufacturing organization.

Tease photo

Bren was Pitch Perfect

The Business Journal has selected Irvine Company Chairman Donald Bren as its Business Person of the Year.

Tease photo

Peregrine Names CEO, to Change Name

Tustin’s Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a drug manufacturer that’s been in a proxy battle, said Roger J. Lias is the company’s new chief executive and president.

Tease photo

Sonendo Gets CFO

Sonendo Inc. appointed Michael Watts chief financial officer.

Tease photo

Presbia Cuts Back; Execs Resign

Presbia PLC’s executive chairman and chief executive have resigned and the eye care device maker said it would cut expenses as it considers a $5 million investment from an affiliate of its majority shareholder.

Tease photo

Another Top Executive Leaves Allergan

Allergan PLC (NYSE: AGN) Chief Operating Officer Robert Stewart will resign to become president and chief executive officer of Amneal Pharmaceuticals LLC starting January 25, according to filings with the Securities and Exchange Commission.

Tease photo

Aerie Gets Early FDA OK

Irvine-based Aerie Pharmaceuticals received Food and Drug Administration approval for its glaucoma eye drop Rhopressa two months ahead of an informal goal date in February.

Tease photo